-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

SCI-43 The Role of Hepcidin in Health And Disease

Program: Scientific Program
Session: Take a Breath: Heme, Iron, and Cellular Metabolism
Saturday, December 5, 2015, 7:30 AM-9:00 AM
W331, Level 3 (Orange County Convention Center)
Saturday, December 5, 2015, 2:00 PM-3:30 PM
W331, Level 3 (Orange County Convention Center)

Martina U. Muckenthaler, PhD

University of Heidelberg, Heidelberg, Germany

Imbalances of iron homeostasis account for some of the most common human diseases. Pathologies result from both, iron deficiency or overload and frequently affect the hepcidin/ferroportin regulatory system that balances systemic iron metabolism. The small hepatic peptide hormone hepcidin orchestrates systemic iron fluxes and controls plasma iron levels by binding to the iron exporter ferroportin on the surface of iron releasing cells, triggering its degradation and hence reducing iron transfer to transferrin. Hepcidin thus maintains transferrin saturation at physiological levels assuring adequate iron supplies to all cell types. My presentation will focus on mechanisms that control hepcidin and ferroportin expression as well as on pathologies that arise when this key regulatory circuitry underlying systemic iron homeostasis is disrupted.

Disclosures: No relevant conflicts of interest to declare.

Previous Presentation | Next Presentation >>